Skip to main content

Pritzker Jennifer N.'s Form 4 filing

Orthopediatrics Corp (KIDS) · filed Dec 13, 2021

Accession no.
0000899243-21-047947
Filed
Dec 13, 2021
Trade date
Dec 9-10, 2021
Filing delay
4 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions. Open-market purchases total $149.8K. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Pritzker Jennifer N.CIK 000185016510% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Dec 9, 2021Common StockPPurchaseAcquired+1,000$60.42F1+$60,42010,900Direct
Dec 9, 2021Common StockPPurchaseAcquired+500$60.24+$30,1201,300Indirect
Dec 9, 2021Common StockPPurchaseAcquired+500$60.36F3+$30,1801,300Indirect
Dec 10, 2021Common StockPPurchaseAcquired+500$58.26+$29,130707Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $60.345 to $60.50 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1) to this Form 4.

Referenced by the price of 1 transaction in Table I.

F3

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $60.235 to $60.37 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)